Logo image
Se connecter
Doxorubicin-loaded nanoparticles for patients with advanced hepatocellular carcinoma after sorafenib treatment failure (RELIVE): a phase 3 randomised controlled trial
Article de revue   Avec comité de lecture

Doxorubicin-loaded nanoparticles for patients with advanced hepatocellular carcinoma after sorafenib treatment failure (RELIVE): a phase 3 randomised controlled trial

Philippe Merle, Jean-Frederic Blanc, Jean-Marc Phélip, Gilles Pelletier, Jean-Pierre Bronowicki, Yann Touchefeu, Georges Pageaux, Rene Gerolami, François Habersetzer, Eric Nguyen-Khac, …
The Lancet Gastroenterology & Hepatology, Vol.4(6), pp.454-465
06/2019
PMID: 30954567

Fichiers et liens (1)

url
Find in HALAfficher

Indicateurs

1 Consultations de la notice

Détails

Logo image